Shir Jing Ho

Summary

Country: Australia

Publications

  1. pmc Ximelagatran: direct thrombin inhibitor
    Shir Jing Ho
    Department of Clinical Haematology, Cancer Care Centre, St George Hospital, Gray St, Kogarah, NSW 2217, Australia
    Vasc Health Risk Manag 2:49-58. 2006
  2. doi request reprint Platelet function testing in uraemic patients
    Shir Jing Ho
    SEALS, Department of Haematology, St George Hospital, Gray St, Kogarah, NSW 2217, Australia
    Hematology 13:49-58. 2008

Collaborators

Detail Information

Publications2

  1. pmc Ximelagatran: direct thrombin inhibitor
    Shir Jing Ho
    Department of Clinical Haematology, Cancer Care Centre, St George Hospital, Gray St, Kogarah, NSW 2217, Australia
    Vasc Health Risk Manag 2:49-58. 2006
    ..It has also been shown to be more effective than aspirin alone for prevention of recurrent major cardiovascular events in patients with recent myocardial infarction...
  2. doi request reprint Platelet function testing in uraemic patients
    Shir Jing Ho
    SEALS, Department of Haematology, St George Hospital, Gray St, Kogarah, NSW 2217, Australia
    Hematology 13:49-58. 2008
    ..Several newer rapid assays of platelet function are able to provide a means of assessing primary haemostasis, but have not been specifically assessed in uraemic patients...